|
Sign In to gain access to subscriptions and/or personal tools.
|
Effect of Oral Gavage Dosing Regimens in Female Tg rasH2 Transgenic Mice
Daniel Morton
Pfizer Drug Safety Evaluation, Skokie, Illinois, USA, dan.g.morton{at}pfizer.com
Rani S. Sellers
Pfizer Drug Safety Evaluation, Skokie, Illinois, USA
Sylvia M. Furst
Pfizer Drug Safety Evaluation, Skokie, Illinois, USA
Kristen D. Hawley
Pfizer Drug Safety Evaluation, Skokie, Illinois, USA
Jeffrey R. May
Pfizer Drug Safety Evaluation, Skokie, Illinois, USA
Female Tg rasH2 (CB6F1/Jic-TgrasH2@Tac) mice were administered water once daily, water twice daily with 8 or 12 hours between doses, 1% sodium dodecyl sulfate in water (1% SDS) once daily, or 1% SDS twice daily with 12 hours between doses by oral gavage at volumes of 10 ml/kg/day for 28 or 29 consecutive days. A control group of mice received no treatment and no sham manipulation. There were no significant differences in body weight or food consumption between treated groups and untreated control mice. Mean weights of spleens, livers, and thymuses were lower than control values in most groups of mice subjected to gavage. Focal or multifocal loss of thymic cortical architecture was observed in 13 of 50 mice distributed among all groups (including naïve controls), however only in one instance was this finding suggestive of a precursor to neoplasia. This study demonstrated that Tg rasH2 mice can tolerate once or twice daily gavage dosing with water or vehicle containing 1% SDS. Loss of thymic cortical architecture was a common incidental finding in female Tg rasH2 mice.
Key Words: Carcinogenicity • gavage • mouse • sodium dodecyl sulfate • Tg rasH2 • thymus • transgenic.
References
- Dunnick, J.K., and Hailey, J.R. (1996). Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res 56, 4922—6.[Abstract/Free Full Text]
- Dunnick, J.K., Hardisty, J.F., Herbert, R.A., Seely, J.C., Furedi-Machacek, E.M., Foley, J.F., Lacks, G.D., Stasiewicz, S., and French, F.E. (1997). Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (±) mice. Toxicol Pathol 25, 533—40.[Abstract/Free Full Text]
- Green, T., Toghill, A., Lee, R., Moore, R., and Foster, J. (2002). The development of forestomach tumours in the mouse following exposure to 2-butoxyethanol by inhalation: studies on the mode of action and relevance to humans. Toxicology 180, 257—73.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- International Conference on Harmonization ( 1998). Guidance on testing for carcinogenicity of pharmaceuticals. Fed Reg 63(35), 8983—6.
- Ito, M., Hirose, M., and Takahashi, S. (1993). Cell proliferation and forestomach carcinogenesis. Environ Health Perspec 101(Suppl 5), 107—10.[Medline]
[Order article via Infotrieve]
- Kaneko, M., Morimura, K., Nishikawa, T., Wanibuchi, H., Takada, N., Osugi, H., Kinoshita, H., and Fukushima, S. (2002). Different genetic alterations in rat forestomach tumors induced by genotoxic and non-genotoxic carcinogens. Carcinogenesis 23, 1729—35.[Abstract/Free Full Text]
- Kroes, R., and Webster, P.W. (1986). Forestomach carcinogens: possible mechanisms of action. Fd Chem Toxicol 24, 1083—9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Morton, D., Alden, C.L., Roth, A.J., and Usui, T. (2002). The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol 30, 139—46.[Abstract/Free Full Text]
- Takaoka, M., Sehata, S., Maejima, T., Imai, T., Mikinori, T., Satoh, H., Toyosawa, K., Tanakamaru, Z.-Y., Adachi, T., Hisada, S., Ueda, M., Ogasawara, H., Matsumoto, M., Kobayashi, K., Mutai, M., and Usui, T. (2003). Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice. Toxicol Pathol 31, 191—9.[Abstract/Free Full Text]
- Tamaoki, N. (2001). The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Toxicol Pathol 29(Suppl), 81—9.[Abstract/Free Full Text]
- United Nations Environment Programme (1997 ). Chemicals Screening Information Data Set for High Volume Chemicals, Vol. 4/II.
 http://www.chem.unep.ch/irptc/sids/volume4/42/151_21_3.pdf - Usui, T., Mutai, M., Hisada, S., Takoaka, M., Soper, K.A., McCullough, B., and Alden, C.L. (2001). CB6F1-rasH2 mouse: overview of available data. Toxicol Pathol 29 (Suppl), 90—108.[Abstract/Free Full Text]
- Ward, J.M., Mann, P.C., Morishima, H., and Frith, C.H. (1999). Thymus, spleen, and lymph nodes. In Pathology of the Mouse, (R. R. Maronpot, ed.), pp.336—7. Cache River Press, Vienna, IL.
- Yamamoto, S., Urano, K., Koizumi, H., Wakana, S., Hioki, K., Mitsumori, K., Kurokawa, Y., Hayashi, Y., and Nomura, T. (1998). Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ Health Perspect 106(Suppl. 1), 57— 69.
Toxicologic Pathology, Vol. 32, No. 4,
413-417 (2004)
DOI: 10.1080/01926230490457567
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
